🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of the Phase I part of this clinical research study is to find the...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-02
Trial ID
NCT01409174
Treatments Being Tested
Temozolomide is the standard adjuvant chemotherapy of newly-diagnosis malig...
Status
Unknown
Location
Beijing Tiantan Hospital Affiliated to Capital Medial University
Start Date
2012-08
Trial ID
NCT01670890
Treatments Being Tested
This is a "tissue banking and data review" research study that also has a "...
Status
Terminated
Location
Tufts Medical Center
Start Date
2009-11
Trial ID
NCT01014767
The goal of this clinical research study is to learn if treatment with Temo...
Status
Terminated
Location
U.T.M.D. Anderson Cancer Center
Start Date
2007-03
Trial ID
NCT00505635
Treatments Being Tested
This is a a multicenter, randomized, controlled, phase III trial comparing ...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2014-02
Trial ID
NCT03435302
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
U.T. M.D. Anderson Cancer Center
Start Date
2009-09
Trial ID
NCT00970996
Treatments Being Tested
This phase III trial tests how well the addition of dinutuximab to Inductio...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2024-04-19
Trial ID
NCT06172296
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of gamma-secr...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2010-08
Trial ID
NCT01196416
Primary Objectives To compare progression free survival (PFS), the time fr...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT01260103
Treatments Being Tested
Currently, the prognosis of recurrent high-grade gliomas is still dismal wi...
Status
Completed
Location
Huashan Hospital
Start Date
2014-10
Trial ID
NCT02263105
Treatments Being Tested